MedTrace Logo

HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China

NCT01293279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 997

Last updated 2011-10-07

No results posted yet for this study

Summary

The primary objective of this study is to estimate the distributions of HCV viral/human genotypes (including IL28B and inosine triphosphatase, ITPA), and HCV RNA level among ITPA gene among 1000 Han ethnic Chinese patients with HCV who are antiviral treatment naive at the time the study is conducted.

Conditions

  • Hepatitis C

Sponsors & Collaborators

Principal Investigators

  • Lai Wei, MD · Peking University People's Hospital, Peking University Hepatology Institute

  • Hong Li, Ph.D., MPH · Bristol-Myers Squibb

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01293279 on ClinicalTrials.gov